"Empagliflozin significantly reduced CI-AKI incidence in PCI patients by enhancing renal function markers, including eGFR and ...

Though highly effective, medications for the prevention of chronic kidney disease progression are under-utilized, emphasizing the need for better use of prognostic tools.

In Japan, interest rates are set by the Bank of Japan's Policy Board in its Monetary Policy Meetings. The BoJ's official interest rate is the discount rate. Monetary Policy Meetings produce a ...

The effects of SGLT2 inhibitors on the kidney to prevent ... Participants were at high risk for progression with estimated glomerular filtration rate of 25 mL/min/1.73 m 2 to 75 mL/min/1.73 ...

Annual inflation stayed steady at 2.2% for the year to December. But despite landing slightly higher than Reserve Bank forecasts, a 50-basis-point Official Cash Rate (OCR) cut in February remains ...

The SGLT2 inhibitors, as a class, lead to similar treatment benefits at comparable clinical doses, although there are some discrepancies between them, particularly when dapagliflozin (Farxiga; ...

Opens in a new tab or window Comparative effectiveness study followed adults with type 2 diabetes who initiated SGLT-2 inhibitors from 2014 to 2020. Real-world outcomes largely point to comparable ...

Adults with overweight or obesity and type 2 diabetes who are given the sodium glucose cotransporter 2 (SGLT-2) inhibitor drug dapagliflozin alongside moderate calorie restriction achieve much ...

WASHINGTON, DC - DECEMBER 13: U.S. Federal Reserve Board Chairman Jerome Powell speaks during a news ... [+] conference at the headquarters of the Federal Reserve on December 13, 2023 in ...

UK pay after inflation has risen at its fastest rate for more than three years, driven by strong wage growth in the private sector. Pay packets increased on average by 3.4% between September and ...

SGLT2 inhibitor use might be renoprotective in patients with ADPKD, but could increase kidney volume. Dapagliflozin might help protect kidney function in patients with autosomal dominant polycystic ...